Erratum: GLOB-1: A prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients (Annals of Oncology) (2002) vol. 13 (1853-1861))
dc.contributor.author | Souquet P.J. | |
dc.contributor.author | Price A. | |
dc.contributor.author | Jaworski M. | |
dc.contributor.author | Burillon J.P. | |
dc.contributor.author | Aubert D. | |
dc.contributor.author | Fernandez O. | |
dc.contributor.author | Lewis C. | |
dc.contributor.author | De Souza P. | |
dc.contributor.author | Bosque L. | |
dc.contributor.author | Rodrigues Pereira J. | |
dc.contributor.author | Kolec V. | |
dc.contributor.author | Marel M. | |
dc.contributor.author | Astoul P. | |
dc.contributor.author | Jounieaux A. | |
dc.contributor.author | Riou R. | |
dc.contributor.author | Souquet P.J. | |
dc.contributor.author | Tack V. | |
dc.contributor.author | Deppermann K.M. | |
dc.contributor.author | Gatzmeier U. | |
dc.contributor.author | Koschel G. | |
dc.contributor.author | Kreuser E.D. | |
dc.contributor.author | Schlimok G. | |
dc.contributor.author | Von Pawel J. | |
dc.contributor.author | Isokangas O.P. | |
dc.contributor.author | Mattson K. | |
dc.contributor.author | Torrecillas L. | |
dc.contributor.author | Lira Puerto V. | |
dc.contributor.author | Barroso N. | |
dc.contributor.author | Van Klaveren R. | |
dc.contributor.author | Gallardo D. | |
dc.contributor.author | Utraka B. | |
dc.contributor.author | Barnardt P. | |
dc.contributor.author | Tan E.H. | |
dc.contributor.author | Sevilla Garcia I. | |
dc.contributor.author | Moreno Nogueira J.A. | |
dc.contributor.author | Betticher D. | |
dc.contributor.author | Stahel R. | |
dc.contributor.author | Wernli M. | |
dc.contributor.author | Shih J.F. | |
dc.contributor.author | Clark P. | |
dc.contributor.author | Harper P. | |
dc.contributor.author | Price A. | |
dc.date.accessioned | 2011-05-15T16:15:30Z | |
dc.date.available | 2011-05-15T16:15:30Z | |
dc.date.issued | 2003 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Erratum | |
dc.identifier.citation | Annals of Oncology | |
dc.identifier.citation | 14 | |
dc.identifier.citation | 2 | |
dc.identifier.issn | 09237534 | |
dc.identifier.other | 10.1093/annonc/mdg083 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13368 | |
dc.subject | erratum | |
dc.subject | error | |
dc.subject | priority journal | |
dc.title | Erratum: GLOB-1: A prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients (Annals of Oncology) (2002) vol. 13 (1853-1861)) | |
dc.type | Erratum |